About this trial
The purpose of this study is to explore if GPCR-autoantibodies:
1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Inhabitant in the Region of Southern Denmark
BMI above 30kg/m2
age between 18 and 60 years.
Disqualifiers
individuals previously treated with GLP-1RA medication for any indication
Individuals who have previously undergone bariatric surgery
Individuals with type 1 diabetes
Trial population
The South Danish Obesity Initiative (SDOI) cohort. This is an ongoing clinical initiative offering screening of a broad panel of obesity related diseases to individuals with BMI above 30 kg/m² and age between 18 and 60 years. People are referred from their general practitioners or from hospital departments and undergo screening for diabetes, dyslipidemia, obstructive sleep apnea, metabolic associated steatohepatitis and hypertension. In addition, a cohort of people with BMI 18.5 to 30 kg/m² has been assessed with an identical screening program with the purpose of serving as a control group. Only participants who gave informed consent to use their data for research purposes are included in this study.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Exploring the pressence and role of GPCR-autoantibodies in obesity
explore the pressence of GPCR-autoantibodies in people living with obesity, and if there is any association with the degree of obesity
Secondary outcomes
Exploring the association between GPCR-autoantibodies and obesity related diseases
explore if the pressence of GPCR-autoantibodies is associated with obesity related diseases (pre-diabetes, type 2 diabetes and metabolic syndrome) in people living with obesity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Claus Bogh Juhl
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: